NEW YORK (GenomeWeb News) – Sequenom reported after the close of the market Thursday that its first-quarter revenues grew 10 percent year over year, driven by a sharp uptick in diagnostic services that was somewhat offset by a decline in genetic analysis product sales and services.

The San Diego-based molecular diagnostics firm brought in total revenues of $14.9 million for the three-month period ended March 31, compared to $13.5 million for the first quarter of 2011. It fell short of Wall Street's consensus estimate of $16.3 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The World Health Organization calls for the public release of clinical trial results within a year of the completion of data collection.

In Science this week: measles virus nucleocapsid structure, and more.

African and US health officials work to establish an Africa-wide Centres for Disease Control and Prevention.

Nature has retracted a 2002 epigenetics paper for image manipulation.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.